The change follows last week's announcement by Food and Drug Administration officials that they would limit approval of Covid shots.

A colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

CNW/ -- (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating ...

Here's our list of the leaders in Massachusetts tech, biotech and climate tech who aren't just surviving, but moving their ...

On May 13th, 1980, an F3 tornado traveled 11 miles from the west side of Kalamazoo through downtown before lifting near Comstock. Five people were killed and 79 were seriously injured. Bronson Park, ...

Despite recent declines, we believe Pfizer stock is a compelling buy right now, with its current price of around $23 likely ...

Pfizer Inc. closed 26.70% short of its 52-week high of $31.54, which the company achieved on July 30th.

Known as Enflonsia, the drug will compete for market share with Sanofi and AstraZeneca’s in-demand Beyfortus, which quickly ...

Pfizer is gearing up for a federal preemption defense, its first fight designed to wipe out more than 400 lawsuits over ...

Shares of Pfizer Inc. PFE advanced 1.16% to $23.45 Thursday, on what proved to be an all-around great trading session for the ...

The global alpha-1 antitrypsin deficiency (AATD) market is expanding, driven by advances in diagnosis, treatment, and growing awareness. Key players like Grifols, CSL Behring, and Pfizer lead ...